Copyright
©The Author(s) 2016.
World J Diabetes. Aug 25, 2016; 7(16): 333-341
Published online Aug 25, 2016. doi: 10.4239/wjd.v7.i16.333
Published online Aug 25, 2016. doi: 10.4239/wjd.v7.i16.333
Figure 1 This drawing identifies many of the unresolved treatment questions pertaining to the evaluation and treatment of patients with diabetic retinopathy.
The question marks highlight areas of controversy that are discussed in greater detail in the manuscript. VEGF: Vascular endothelial growth factor.
- Citation: Stewart MW. Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J Diabetes 2016; 7(16): 333-341
- URL: https://www.wjgnet.com/1948-9358/full/v7/i16/333.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i16.333